Valerie Fuller, DO
Dermatology · Fairlawn, OHNPI 1275503724
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 619 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations.
Across 619 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$831
- Regeneron Healthcare Solutions, Inc.$826
- Novartis$808
- Lilly USA, LLC$765
- plus $5K from 33 others
What the payments were for
- Food & beverage$11,64195%
- Education$6345%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 147 | $2,308 |
| Johnson & Johnson | 67 | $1,316 |
| Sun Pharmaceutical Industries Inc. | 34 | $831 |
| Regeneron Healthcare Solutions, Inc. | 39 | $826 |
| Novartis | 42 | $808 |
| Lilly USA, LLC | 37 | $765 |
| Sanofi | 25 | $592 |
| LEO Pharma Inc. | 22 | $588 |
| E.r. Squibb & Sons, L.L.C. | 35 | $551 |
| UCB, Inc. | 16 | $467 |
| Incyte Corporation | 14 | $413 |
| Pfizer | 17 | $311 |
| Mayne Pharma Commercial LLC | 22 | $310 |
| Galderma Laboratories, L.p. | 16 | $255 |
| Boehringer Ingelheim | 6 | $229 |
| Dermavant Sciences, Inc. | 11 | $219 |
| Barco, Inc. | 1 | $173 |
| Organon | 9 | $163 |
| Amgen | 8 | $159 |
| Arcutis Biotherapeutics, Inc. | 9 | $149 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $135 |
| Janssen Scientific Affairs, LLC | 2 | $135 |
| EPI Health, LLC | 6 | $92 |
| Bristol Myers Squibb | 4 | $89 |
| Dermira, Inc. | 3 | $82 |
| Journey Medical Corporation | 3 | $51 |
| LNHC, Inc | 2 | $37 |
| Novum Pharma, LLC | 2 | $30 |
| Almirall LLC | 2 | $29 |
| Taro Pharmaceuticals USA, Inc. | 2 | $24 |
| Medtronic | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Sandoz | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Botanix SB Inc | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Fresenius Kabi USA, LLC | 1 | $14 |
| Nobelpharma America, LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,276 in reported general payments places this provider in the 80th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $56,065 |
| Tacrolimus | 17 | $3,925 |
| Fluorouracil | 43 | $3,567 |
| Clobetasol Propionate | 67 | $2,248 |
| Fluocinonide | 80 | $2,137 |
| Halobetasol Propionate | 35 | $1,825 |
| Ofloxacin | 14 | $1,814 |
| Ketoconazole | 101 | $1,760 |
| Metronidazole | 37 | $1,704 |
| Triamcinolone Acetonide | 127 | $441 |
| Doxycycline Hyclate | 29 | $420 |
| Ciclopirox | 18 | $414 |
| Hydrocortisone | 103 | $354 |
| Roflumilast | 11 | $337 |
| ErythromycinErythromycin Base | 14 | $206 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fairlawn
- James LibeccoFairlawn$1.1M
- Matthew ZirwasBexley$3.3M
- George DrewMarion$1.9M
- Rocco SerraoDayton$1.7M
- Pranav ShethWest Chester$978K
- Dawn MerrittAthens$844K
- Neil KormanCleveland$824K
- Joshua GrosshandlerWesterville$479K
- Lorie GottwaldToledo$460K
- Gregory DelostMayfield Heights$383K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.